. Author manuscript; available in PMC: 2016 May 18.

Published in final edited form as: Prostate Cancer Prostatic Dis. 2015 Oct 13;19(1):40–45. doi: 10.1038/pcan.2015.46

Table 2. Baseline characteristics of the patients included in the present tissue microarray study.

ADT=androgen deprivation therapy. PSA=prostate specific antigen. NCCN=National Comprehensive Cancer Network.

Clinical and Pathologic Characteristics of the Patients	N (%), range

Age, years	63 (47–73)
Race/Ethnicity
White (%)	104 (51)
Black (%)	99 (48)
Hispanic (%)	0 (0)
PSA at the time of surgery, ng/dl	7 (1–75)
Pathologic Gleason sum
≤6	42 (21)
7	138 (67)
8–10	25 (12)
NCCN Risk Group
Low	96 (47)
Intermediate	68 (33)
High	40 (20)
Extracapsular extension (%)	56 (27)
Seminal Vesicle Invasion (%)	31 (15)
Positive Surgical Margins (%)	125 (61)
Prior ADT, %	0 (0)